Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Zoetis has recently seen its MiPet Easecto ectoparasiticide for dogs gain approval from the European Medicines Agency's Committee for Medicinal Products for Veterinary Use.
MSD Animal Health is close to extending the indications for its leading Bravecto portfolio in Europe with a new approval.
The growing influence of Amazon and other online pet product retailers may result in some new sales strategies among the animal health majors.
The US animal health industry is an "integral part of the US economy" worth around $9.9 billion in revenues, according to a new report from the Animal Health Institute (AHI).
The US FDA has issued draft guidance on proprietary names for new animal drugs.
At the recent Animal Health Investment Europe forum in London, Animal Pharm editor Joseph Harvey quizzed a panel of experts on the future of industry innovation. Below is a video of the full panel discussion featuring Boehringer Ingelheim Animal Health, Antelliq and ViroVet.
Virbac hopes its commercial expertise will be a differentiator when competing against the larger companies in animal health.
Bioveta has made a gradual sales trek eastwards from central Europe. Animal Pharm analyst Malcolm Flanagan spoke to Eastern Europe's third-largest animal health company about its latest strategic moves in Asia.
Zoetis has made trademark applications for Simparica Trio in the US and Europe.
The importance of controlling flies in livestock production has been emphasized by an Italian expert in vectors.
US livestock products firm Y-Tex has launched a new cattle insecticide ear tag.
The European animal health industry again showed healthy year-on-year growth with sales of vaccines now equal to that of parasiticides, according to AnimalhealthEurope's annual report.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.